Niina Aaltonen

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Gene Expression

Risk Assessment

Top Venues

Cellular and molecular life sciences : CMLS

This page only lists publications with an associated author ORCID identifier.

Publications

Jasmin Huttunen, Niina Aaltonen, Laura Helminen, Kirsi Rilla, Jorma J Palvimo
EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells. Cellular and molecular life sciences : CMLS 81 (1) (2024)
Jasmin Huttunen, Niina Aaltonen, Laura Helminen, Kirsi Rilla, Jorma J Palvimo
EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells. Cellular and molecular life sciences : CMLS 81 (1) (2024)
Jasmin Huttunen, Niina Aaltonen, Laura Helminen, Kirsi Rilla, Jorma J Palvimo
EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells. Cellular and molecular life sciences : CMLS 81 (1) (2024)
Jasmin Huttunen, Niina Aaltonen, Laura Helminen, Kirsi Rilla, Jorma J Palvimo
EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells. Cellular and molecular life sciences : CMLS 81 (1) (2024)